Published in J Biol Chem on March 10, 1983
The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol (2013) 3.59
Transport of lipopolysaccharide across the cell envelope: the long road of discovery. Nat Rev Microbiol (2009) 2.07
Composition and antigenic activity of the oligosaccharide moiety of Haemophilus influenzae type b lipooligosaccharide. Infect Immun (1985) 1.62
Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect Immun (1984) 1.57
Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect Immun (1984) 1.41
Macrophage activation by monosaccharide precursors of Escherichia coli lipid A. Proc Natl Acad Sci U S A (1985) 1.39
Chemical characterization of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.36
Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infect Immun (1987) 1.04
Comparison of the capacity of two lipid A precursor molecules to express the local Shwartzman phenomenon. Infect Immun (1985) 0.97
New cysE-pyrE-linked rfa mutation in Escherichia coli K-12 that results in a heptoseless lipopolysaccharide. J Bacteriol (1985) 0.96
A pyrophosphate bridge links the pyruvate-containing secondary cell wall polymer of Paenibacillus alvei CCM 2051 to muramic acid. Glycoconj J (2000) 0.91
Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4. Biochem J (1985) 0.86
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Discovering high-affinity ligands for proteins: SAR by NMR. Science (1996) 7.10
Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature (1997) 4.55
Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature (1994) 4.49
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell (2000) 4.05
Structural basis for the inhibition of caspase-3 by XIAP. Cell (2001) 3.91
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature (2001) 3.22
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene (2006) 3.10
NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature (1997) 3.04
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci (2000) 3.00
Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A (2001) 2.60
Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature (1995) 2.59
Structure of the metal clusters in rabbit liver metallothionein. Proc Natl Acad Sci U S A (1980) 2.40
A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments. J Biomol NMR (1993) 2.35
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature (1999) 2.18
Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol Cell Biol (1997) 2.15
A computer-based protocol for semiautomated assignments and 3D structure determination of proteins. J Biomol NMR (1994) 2.14
31P NMR studies of the solution structure and dynamics of nucleosomes and DNA. Nucleic Acids Res (1979) 1.98
Model for mammalian metallothionein structure. Proc Natl Acad Sci U S A (1983) 1.91
NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J Biol Chem (2000) 1.88
Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J (1997) 1.83
Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3". Biochem Biophys Res Commun (1977) 1.82
Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistance. Nat Struct Biol (1997) 1.82
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A (2000) 1.75
Solution structure of a pleckstrin-homology domain. Nature (1994) 1.68
NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor Trio. Cell (1998) 1.67
NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature (1998) 1.65
Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a. Biochemistry (1989) 1.63
Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J (1999) 1.62
Structural characterization of the FK506 binding protein unfolded in urea and guanidine hydrochloride. J Mol Biol (1994) 1.58
Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother (1987) 1.58
Side chain and backbone assignments in isotopically labeled proteins from two heteronuclear triple resonance experiments. FEBS Lett (1992) 1.56
Structure of an invertebrate metallothionein from Scylla serrata. J Biol Chem (1982) 1.56
Evidence for site-selective metal binding in calf liver metallothionein. J Biol Chem (1982) 1.55
Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate. Biochemistry (1995) 1.53
Location of polar substituents and fatty acyl chains on lipid A precursors from a 3-deoxy-D-manno-octulosonic acid-deficient mutant of Salmonella typhimurium. Studies by 1H, 13C, and 31P nuclear magnetic resonance. J Biol Chem (1985) 1.46
Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature (1993) 1.44
Structure and metal-binding properties of lipopolysaccharides from heptoseless mutants of Escherichia coli studied by 13C and 31P nuclear magnetic resonance. J Biol Chem (1983) 1.44
NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J Med Chem (1997) 1.41
Molecular properties of acyl carrier protein derivatives. J Biol Chem (1981) 1.40
Privileged molecules for protein binding identified from NMR-based screening. J Med Chem (2000) 1.40
Discovering high-affinity ligands for proteins. Science (1997) 1.33
Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat Struct Biol (1996) 1.25
Phosphatidylinositol 4,5-bisphosphate binding to the pleckstrin homology domain of phospholipase C-delta1 enhances enzyme activity. J Biol Chem (1996) 1.23
Solution structure of the ets domain of Fli-1 when bound to DNA. Nat Struct Biol (1994) 1.20
An approach for high-throughput structure determination of proteins by NMR spectroscopy. J Biomol NMR (2000) 1.18
Equilibrium denaturation of recombinant human FK binding protein in urea. Biochemistry (1993) 1.18
Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst (1975) 1.17
High-throughput nuclear magnetic resonance-based screening. J Med Chem (1999) 1.15
113Cd NMR study of a metallothionein fragment. Evidence for a two-domain structure. J Biol Chem (1982) 1.14
Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci U S A (1996) 1.14
NMR-based screening in drug discovery. Q Rev Biophys (1999) 1.10
Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Mol Cell Biol (1997) 1.08
Nuclear magnetic resonance spectroscopy. Carbon-13 spin-lattice relaxation time measurements of amino acids. Proc Natl Acad Sci U S A (1974) 1.07
NMR studies of the anti-apoptotic protein Bcl-xL in micelles. Biochemistry (2000) 1.07
Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (1990) 1.06
NMR spectroscopic studies of I = 1/2 metal ions in biological systems. Biochem Cell Biol (1998) 1.04
1H NMR studies on bovine cyclophilin: preliminary structural characterization of this specific cyclosporin A binding protein. Biochemistry (1986) 1.03
Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J (2001) 1.03
Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J Med Chem (1999) 1.01
Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc. J Biol Chem (1995) 1.00
Backbone dynamics of the C-terminal domain of Escherichia coli topoisomerase I in the absence and presence of single-stranded DNA. Biochemistry (1996) 1.00
Relative contributions of chemical exchange and other relaxation mechanisms in protein solutions and tissues. Magn Reson Med (1989) 1.00
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. J Med Chem (1999) 0.99
Solution structure of the C-terminal single-stranded DNA-binding domain of Escherichia coli topoisomerase I. Biochemistry (1995) 0.99
Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials. Immunology (1982) 0.98
A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells. Biochemistry (1992) 0.98
Pharmacology of systemically administered domoic acid in mice. Can J Physiol Pharmacol (1991) 0.98
Polycation binding to isolated lipopolysaccharide from antibiotic-hypersusceptible mutant strains of Escherichia coli. Antimicrob Agents Chemother (1988) 0.98
Comparative behavioural toxicity of domoic acid and kainic acid in neonatal rats. Neurotoxicol Teratol (2001) 0.98
Structure elucidation of the metal-binding sites in metallothionein by 113Cd NMR. Fed Proc (1982) 0.97
Solution structure and function of a conserved protein SP14.3 encoded by an essential Streptococcus pneumoniae gene. J Mol Biol (2001) 0.97
A 4D HCCH-TOCSY experiment for assigning the side chain 1H and 13C resonances of proteins. J Biomol NMR (1992) 0.96
Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide. Biochemistry (1997) 0.96
Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc Natl Acad Sci U S A (1995) 0.95
Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. Biochemistry (1995) 0.95
Use of deuterium labeling in NMR: overcoming a sizeable problem. Structure (1996) 0.95
Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1. Proc Natl Acad Sci U S A (1998) 0.94
31P nuclear magnetic resonance evidence for polyphosphoinositide associated with the hydrophobic segment of glycophorin A. Biochemistry (1977) 0.94
pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands. Biochim Biophys Acta (1994) 0.93
Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry (1996) 0.93
RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors. Oncogene (2006) 0.93
[13C]Valine metabolism in methylmalonicacidemia using nuclear magnetic resonance: propinonate as an obligate intermediate. Proc Natl Acad Sci U S A (1975) 0.92
Structural elements pertinent to the interaction of cyclosporin A with its specific receptor protein, cyclophilin. Biochem Pharmacol (1990) 0.91
Determination of the anomeric specificity of the Escherichia coli CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase by 13C NMR spectroscopy. J Biol Chem (1985) 0.91
Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry (1994) 0.91
Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution. Biochemistry (1993) 0.90
1H NMR studies on bovine cyclophilin: preliminary structural characterization of its complex with cyclosporin A. Biochemistry (1990) 0.90
The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein. Proc Natl Acad Sci U S A (1994) 0.89
Nuclear magnetic resonance spectroscopy: reinvestigation of carbon-13 spin-lattice relaxation time measurements of amino acids. Proc Natl Acad Sci U S A (1975) 0.89
113Cd nmr study of the metal cluster structure of human liver metallothionein. J Inorg Biochem (1982) 0.88
Chemical and carbon-13 nuclear magnetic resonance studies of the blood group M and N active sialoglycopeptides from human glycophorin A. J Biol Chem (1981) 0.88
NMR studies of [U-13C]cyclosporin A bound to human cyclophilin B. FEBS Lett (1991) 0.88
Three-dimensional structures of proteins involved in programmed cell death. J Mol Biol (1997) 0.88